Metyrapone Unknown Status Phase 4 Trials for Resistance, Insulin / Obesity / Syndrome, Metabolic Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01620684Cortisol and Nutritional Sympathetic Responsiveness